No Data
No Data
No Data
No Data
No Data
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
Yahoo FinanceApr 3 07:00 ET
Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations
Yahoo FinanceFeb 16 05:33 ET
Earnings Call: Aytu BioPharma Achieves First Positive Operating Income
InvestingFeb 15 15:36 ET
Earnings Call Summary | Aytu BioPharma(AYTU.US) Q2 2024 Earnings Conference
The following is a summary of the Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript:Financial Performance:Aytu BioPharma achieved $5.1 million in adjusted EBITDA, up from the previous year'
moomoo AIFeb 14 23:32 ET · Conference Call
Aytu BioPharma Q2 2024 GAAP EPS $(0.04) Beats $(0.25) Estimate, Sales $22.93M Beat $21.75M Estimate
Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.25) by 84 percent. The company reported quarterly sales of $22.93 million
BenzingaFeb 14 16:16 ET
Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, Vs. Street Est of $21.75M
04:07 PM EST, 02/14/2024 (MT Newswires) -- Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M
MT NewswiresFeb 14 16:07 ET
No Data
No Data
heng heng888 : fda approve but why red. should be green..
71707398OP : hedgies playing games
TraderGuy : Got great news and has been tanking ever since. This is silly